EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dynamic Profiling of Penicillin‐Binding Protein 2a (PBP2a)‐Positive Extracellular Vesicles: Implications for Early Diagnosis and Treatment Monitoring of Methicillin‐Resistant Staphylococcus Aureus Infections

Qianqian Gao iD, Wenwu Zhou, Zhen Shen, Tianchi Chen, Cong Hu, Liang Dong iD, Da Han, Min Li

Journal of Extracellular Vesicles · 2025-07 · 14 (7)

DOI: 10.1002/jev2.70111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 17.07.2025. Verfasst von Qianqian Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Methicillin-Resistant Staphylococcus aureus, Penicillin-Binding Proteins, Staphylococcal Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections caused by methicillin‐resistant staphylococci (MRS), such as methicillin‐resistant Staphylococcus aureus (MRSA), pose significant challenges to public health. The early detection of MRS infections and monitoring of antibiotic resistance profiles are critical for patient management and infection control strategies. Extracellular vesicles (EVs) have emerged as promising biomarkers in infectious disease. By combining single‐particle nano‐flow cytometry and immunoelectron microscopy (immuno‐TEM), we discovered that PBP2a is present on the surface of EVs extracted from MRS. However, whether PBP2a can serve as an EVs‐associated protein marker for diagnosing bacterial infections remains unexplored. Using MRSA as a model strain, mouse models of localized and systemic infections were established, alongside a clinical cohort study, to investigate the dynamics of PBP2a‐positive (PBP2a + ) EVs in plasma following bacterial infection, infection progression, and in response to antimicrobial therapy. In mouse infection models, PBP2a + EVs were detected in plasma, with variable detection rates observed across different infection models. The study found a progressive correlation between increasing plasma PBP2a + EVs levels and non‐specific inflammation markers (CRP, IL‐6) during infection progression. Antimicrobial therapies, however, inversely affected the ratio of PBP2a + EVs. Furthermore, a clinical cohort study confirmed a direct association between the magnitude of PBP2a + EVs in the plasma of patients with MRSA infection and the severity of infection. The investigation highlights the potential of PBP2a + EVs as plasma biomarkers of MRSA antibiotic resistance, particularly during the early stages of resistant infections. Their persistence in plasma throughout the infectious episode makes them valuable indicators for monitoring disease progression and evaluating the efficacy of antibiotic treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMethicillin-Resistant Staphylococcus aureusPenicillin-Binding ProteinsStaphylococcal InfectionsAnimalsMiceHumansBiomarkersFemaleEarly DiagnosisMaleDisease Models, AnimalAnti-Bacterial Agents

Stichwörter der Autor:innen

PBP2adiagnostic biomarkersearly diagnosisextracellular vesiclesmethicillin‐resistant Staphylococcus aureus

Substanzen

Penicillin-Binding ProteinsBiomarkersAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Neurosurgery, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Institute of Molecular Medicine (lMM), Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • School of Nursing, Shanghai Jiao Tong University, Shanghai, China.

ORCID-Profile: Qianqian Gao, Liang Dong

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Natural Science Foundation of Shanghai Municipality
  • 3-Year Action Plan for Strengthening Public Health System in Shanghai

Zitieren

APA

Gao, Q., Zhou, W., Shen, Z., Chen, T., Hu, C., Dong, L., Han, D., & Li, M. (2025). Dynamic Profiling of Penicillin‐Binding Protein 2a (PBP2a)‐Positive Extracellular Vesicles: Implications for Early Diagnosis and Treatment Monitoring of Methicillin‐Resistant Staphylococcus Aureus Infections. Journal of Extracellular Vesicles, 14(7). https://doi.org/10.1002/jev2.70111

Vancouver

Gao Q, Zhou W, Shen Z, Chen T, Hu C, Dong L, et al. Dynamic Profiling of Penicillin‐Binding Protein 2a (PBP2a)‐Positive Extracellular Vesicles: Implications for Early Diagnosis and Treatment Monitoring of Methicillin‐Resistant Staphylococcus Aureus Infections. Journal of Extracellular Vesicles. 2025;14(7). doi:10.1002/jev2.70111

BibTeX
@article{Gao2025,
  author = {Gao, Qianqian and Zhou, Wenwu and Shen, Zhen and Chen, Tianchi and Hu, Cong and Dong, Liang and Han, Da and Li, Min},
  title = {Dynamic Profiling of Penicillin‐Binding Protein 2a (PBP2a)‐Positive Extracellular Vesicles: Implications for Early Diagnosis and Treatment Monitoring of Methicillin‐Resistant Staphylococcus Aureus Infections},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  volume = {14},
  number = {7},
  doi = {10.1002/jev2.70111}
}
Kostenlos starten →